CREX
Creative Realities, Inc.
CREX has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CREX overall, supported by stronger fundamentals and stronger modeled upside.
CREX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Stable |
CREX's revenue is currently strong, and its balance sheet is stable, but its profitability and cash flow are weak.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CREX PE Valuation
CREX has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
CREX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CREX's losses to shrink, with revenue growing.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
CREX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.11 | -$1.99 |
| Q1 2026 | -$1.87 | -$1.86 |
| Q4 2025 | -$0.81 | -$0.47 |
| Q3 2025 | -$0.88 | -729% |
| Q2 2025 | -$0.12 | -$0.03 |
| Q1 2025 | -$0.01 | +$0.21 |
| Q4 2024 | -$0.34 | +$0.01 |
| Q3 2022 | $0.15 | -55% |
CREX is still losing money, but far less than before: $2.11 per share over the past year, against $5.16 at its worst in late 2020.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CREX in the latest year-over-year earnings comparison.
CREX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $21.5M | +65% |
| Q1 2026 | $16.3M | +68% |
| Q4 2025 | $23.9M | +117% |
| Q3 2025 | $10.5M | -27% |
| Q2 2025 | $13M | -0.6% |
| Q1 2025 | $9.7M | -21% |
| Q4 2024 | $11M | -24% |
| Q3 2024 | $14.4M | +25% |
CREX's revenue is recovering but still below its 2022 peak: $22M last quarter, up 65% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -13% | -2.5 points |
| Q1 2026 | -38% | -31 points |
| Q4 2025 | 1.9% | +8.4 points |
| Q3 2025 | -69% | -77 points |
| Q2 2025 | -10% | -15 points |
| Q1 2025 | -7.4% | -6.8 points |
| Q4 2024 | -6.5% | -20 points |
| Q3 2024 | 7.9% | +6.5 points |
CREX's operating margin was −13% last quarter, down 2.5 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over CREX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CREX on profitability, with a higher operating margin.
CREX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $457K | -32% |
| Q1 2026 | -$1.9M | +$551K |
| Q4 2025 | -$7M | -$5.6M |
| Q3 2025 | -$1.7M | -415% |
| Q2 2025 | $672K | -70% |
| Q1 2025 | -$2.5M | -227% |
| Q4 2024 | -$1.4M | +$1.8M |
| Q3 2024 | $543K | -71% |
CREX's free cash flow was −$10M over the past year, against −$3M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CREX on cash generation, producing positive trailing cash flow while its opponent burns cash.
CREX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +16K shares |
| 1 year | +1.2% | +121K shares |
| 3 years | +44% | +3.2M shares |
| 5 years | +211% | +7.2M shares |
CREX has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CREX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2024 | 2.1x | Moderate |
| Q4 2023 | 2.3x | Moderate |
| Q3 2023 | 4.8x | High |
| Q2 2023 | 13.2x | High |
| Q1 2023 | 10.0x | High |
| Q4 2022 | 45.2x | High |
| Q4 2019 | 4.9x | High |
CREX's net debt is about 2.1 years of its operating earnings (EBITDA), down from 10 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CREX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 8.9 | Oversold |
CREX's weekly RSI is 33 (neutral) and its Stochastic is 9 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CREX PE vs Technology Sector
| Metric | CREX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
CREX has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
CREX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 4.4% below |
| 20 week MA | $2.79 | 23% below |
| 50 week MA | $3.20 | 33% below |
| 100 week MA | $2.87 | 25% below |
| 200 week MA | $2.98 | 28% below |
SNDK has stronger trend alignment. CREX is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CREX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.20 | $3.90 | -7.1% |
| 2021 | $3.90 | $4.38 | +12% |
| 2022 | $4.38 | $1.71 | -61% |
| 2023 | $1.71 | $2.36 | +38% |
| 2024 | $2.36 | $2.69 | +14% |
| 2025 | $2.69 | $2.66 | -1.1% |
| 2026 YTD | $2.66 | $2.15 | -19% |
CREX has finished lower in three of the last six years. It's down 19% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CREX on returns for 2026, with the stronger performance.